Metabolic activity of the subthalamic nucleus in a primate model of L-dopa-unresponsive parkinsonism

Neurol Res. 2010 Dec;32(10):1050-3. doi: 10.1179/016164110X12807570509934. Epub 2010 Aug 31.

Abstract

Increased activity of the subthalamic nucleus (STN) is critical in mediating motor symptoms of Parkinson's disease. To determine if altered STN activity also occurs in levodopa (L-Dopa)-unresponsive parkinsonism due to a combined nigral and striatal degeneration, metabolic activity of the STN was assessed using cytochrome oxidase (CO) histochemistry in monkeys with nigral, striatal, or nigral+striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and/or 3-nitropropionic acid (3NP). MPTP- and MPTP+3NP-treated monkeys had a similar parkinsonian score and were clinically indistinguishable. However, CO activity in the STN was significantly increased in MPTP-induced parkinsonism but not in MPTP+3NP-induced striatonigral degeneration. These results indicate that metabolic activity of the STN is normal following a combined nigral+striatal degeneration and may help to understand the lack of effect of STN stimulation in L-Dopa-unresponsive parkinsonism.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Corpus Striatum / drug effects
  • Corpus Striatum / pathology
  • Corpus Striatum / physiopathology
  • Disease Models, Animal
  • Energy Metabolism / physiology*
  • Female
  • Levodopa / administration & dosage*
  • Macaca fascicularis
  • Parkinsonian Disorders / metabolism*
  • Parkinsonian Disorders / physiopathology*
  • Substantia Nigra / drug effects
  • Substantia Nigra / pathology
  • Substantia Nigra / physiopathology
  • Subthalamic Nucleus / drug effects
  • Subthalamic Nucleus / metabolism*
  • Subthalamic Nucleus / physiopathology

Substances

  • Levodopa